Siglec-15 promotes progression of clear renal cell carcinoma
Open Access
- 22 September 2021
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Chinese Medical Journal
- Vol. 134 (21), 2635-2637
- https://doi.org/10.1097/cm9.0000000000001752
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 5 references indexed in Scilit:
- The Significance of Fibrosis Quantification as a Marker in Assessing Pseudo-Capsule Status and Clear Cell Renal Cell Carcinoma PrognosisDiagnostics, 2020
- CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast CancerInternational Journal of Molecular Sciences, 2020
- MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transitionAging, 2020
- Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysisOncoImmunology, 2020
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapyNature Medicine, 2019